Enveric Biosciences Inc (ENVB)
0.84
-0.06
(-6.67%)
USD |
NASDAQ |
May 17, 16:00
0.8228
-0.02
(-2.05%)
After-Hours: 20:00
Enveric Biosciences Cash from Investing (TTM): 0.0117M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0117M |
| September 30, 2023 | 0.0055M |
| June 30, 2023 | -0.0131M |
| March 31, 2023 | -0.0838M |
| December 31, 2022 | -0.5842M |
| September 30, 2022 | -0.7677M |
| June 30, 2022 | 2.306M |
| March 31, 2022 | 2.360M |
| December 31, 2021 | 2.191M |
| September 30, 2021 | 2.336M |
| June 30, 2021 | -0.7191M |
| March 31, 2021 | -0.6758M |
| December 31, 2020 | -0.0441M |
| September 30, 2020 | -0.0566M |
| June 30, 2020 | -0.0566M |
| March 31, 2020 | -0.2158M |
| December 31, 2019 | -0.2843M |
| September 30, 2019 | -0.2097M |
| June 30, 2019 | -2.784M |
| March 31, 2019 | -2.682M |
| December 31, 2018 | -3.639M |
| September 30, 2018 | -3.764M |
| June 30, 2018 | -1.190M |
| March 31, 2018 | -1.173M |
| December 31, 2017 | -0.1699M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.221M |
| June 30, 2017 | -3.376M |
| March 31, 2017 | -4.891M |
| December 31, 2016 | -6.592M |
| September 30, 2016 | -1.747M |
| June 30, 2016 | -0.6821M |
| March 31, 2016 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.784M
Minimum
Jun 2019
2.360M
Maximum
Mar 2022
0.1429M
Average
-0.0566M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
| Societal CDMO Inc (DELISTED) | -8.237M |
| Seelos Therapeutics Inc | -- |
| Cardiff Oncology Inc | 33.50M |
| BioVie Inc | 0.2239M |
| Adial Pharmaceuticals Inc | -- |